Table 2 Baseline patient characteristics
Killip I (n = 1081) | Killip II (N = 48) | Killip III (N = 17) | Killip IV (N = 12) | Total (N = 1158) | |
|---|---|---|---|---|---|
BMI (mean/range) p = 0.29 | 27 (12–51) | 27 (15–37) | 25 (20–36) | 27 (22–31) | 27 (12–51) |
Age (mean/range) p = 0.49 | 67 (28–95) | 72 (47–93) | 73 (45–86) | 67 (45–82) | 67 (28–95) |
Male sex p = 0.15 | 698 (65%) | 32 (67%) | 11 (65%) | 9 (75%) | 750 (65%) |
Smoker p = 0.79 | 314 (29%) | 7 (15%) | 3 (18%) | 4 (33%) | 328 (28%) |
Former smoker p = 0.66 | 412 (38%) | 15 (31%) | 6 (35%) | 4 (33%) | 437 (38%) |
Diabetes Mellitus p = 0.74 | 207 (19%) | 16 (33%) | 8 (47%) | 3 (25%) | 234 (20%) |
Hypertension p = 0.31 | 565 (52%) | 27 (56%) | 12 (71%) | 8 (67%) | 612 (53%) |
Hyperlipidaemia p = 0.37 | 352 (33%) | 14 (29%) | 7 (41%) | 3 (25%) | 376 (33%) |
Prior ACS p = 0.10 | 209 (19%) | 11 (23%) | 3 (18%) | 2 (17%) | 225 (19%) |
Prior PCI p = 0.33 | 168 (16%) | 7 (15%) | 1 (6%) | 0 | 176 (15%) |
Prior CABG p = 0.25 | 62 (6%) | 5 (10%) | 2 (12%) | 0 | 69 (6%) |
Creatinine clearance p = 0.66 | 87 | 72 | 78 | 62 | 86 |